2007•Inpharma WeeklyRequires access
An octreotide implant has been shown to successfully maintain appropriate growth hormone levels in patients with acromegaly
&NA;
Open publisher page 0 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.